Glutamate levels across deep brain structures in patients with a psychotic disorder and its relation to cognitive functioning

BACKGROUND: Patients with psychotic disorders often show prominent cognitive impairment. Glutamate seems to play a prominent role, but its role in deep gray matter (DGM) regions is unclear. AIMS: To evaluate glutamate levels within deep gray matter structures in patients with a psychotic disorder in...

Descripción completa

Detalles Bibliográficos
Autores principales: Broeders, Tommy AA, Bhogal, Alex A, Morsinkhof, Lisan M, Schoonheim, Menno M, Röder, Christian H, Edens, Mirte, Klomp, Dennis WJ, Wijnen, Jannie P, Vinkers, Christiaan H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066676/
https://www.ncbi.nlm.nih.gov/pubmed/35243931
http://dx.doi.org/10.1177/02698811221077199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066676/
https://www.ncbi.nlm.nih.gov/pubmed/35243931
http://dx.doi.org/10.1177/02698811221077199

Ejemplares similares